VJHemOnc is committed to improving our service to you

iwCLL 2019 | Unmet need: CLL patients intolerant to novel therapies

VJHemOnc is committed to improving our service to you

Danielle Brander

Danielle Brander, MD, Duke University School of Medicine, Durham, NC, discusses the treatment of individuals intolerant to novel therapies and how to achieve the same efficacy through alternative routes. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter